National Cancer Research Network: Paediatric Oncology, Disease: Leukaemia (acute), Leukaemia (acute myeloid), Leukaemia (acute lymphoblastic), Paediatrics Cancer Acute lymphoblastic, acute myeloid leukaemia
Conditions
Interventions
The children will be randomised to an immediate group and a delayed control group. The immediate group will attend the workshops straight away, whilst the delayed group will serve as the controls and
Sponsors
Central Manchester University Hospitals NHS Trust (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients aged between 7 and 12 years 2. Treated for leukaemia at Royal Manchester Children's Hospital 3. Parents must be able to receive and understand verbal and written information about the study and give written informed consent 4. Male and female participants
Exclusion criteria
Exclusion criteria: 1. Age under 7 or over 12 years 2. Other types of maligant disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Quality of life 2. Emotional and behavioural functioning Theses are measured immediately before, immediately after intervention, at 12 weeks and at 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Caregiving burden 2. Ffear of medical procedure 3. Self-efficacy These are measured immediately before, immediately after intervention, at 12 weeks and at 6 months. | — |
Countries
England, United Kingdom
Outcome results
None listed